Abbott plans to close its $21 billion acquisition of cancer test maker Exact Sciences on Monday. The companies announced on Friday that they have received all regulatory clearances necessary for ...

Abbott (NYSE: ABT) announced today that it expects to close the acquisition of Exact Sciences on Monday, March 23, 2026.

Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said. Madison-based Exact Sciences is known for its cancer detection technology such as Cologuard. Abbott ...

The Abbott Park, Illinois-based pharmaceutical and medical technology giant Abbott Labs announced when it expects to close the deal.

The deal is believed to be one of the largest for Abbott in a decade and the largest business investment in the Madison’s ...

Abbott (NYSE: ABT) + today said that it completed a public offering of senior notes worth $20 billion in total. The company ...

Abbott (NYSE: ABT) today announced that it expects to close the acquisition of Exact Sciences on Monday, March 23, 2026. The announcement follows receipt of all regulatory clearances necessary for ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025. On February 20, the company ...

For a third consecutive year, a deal involving a health care-focused company is among the state’s largest mergers and acquisitions of the past year. In ...

Exact SciencesEXAS stock crashed to a three-year low Thursday as the Street debated the merits of its licensing deal for a blood-based colon cancer test. The company already developed a blood-based ...

Under the collab, Walgreens customers will be able to access tools and resources to better understand their colorectal cancer screening options.